Tag: Liver Disease: Misc.
FDA Approves Zepatier for Chronic Hepatitis C
Medication indicated for patients with hepatitis C virus genotypes 1 and 4 infections
Curcumin Cuts Acetaminophen-Induced Hepatotoxicity in Mice
Protective effect of curcumin linked to attenuation of mitochondrial dysfunction
Alcohol Binge Damage May Be Worse Than Previously Thought
Per experimental study of chronic alcohol use combined with frequent binges
AFP Levels Predict Fibrosis Regression After SVR in Hep C
Lower α-fetoprotein, HCV type 2 tied to liver fibrosis regression after sustained virological response
Burden, Costs of Gastrointestinal, Liver Disease Estimated in U.S.
GI hemorrhage is most common diagnosis leading to hospitalization, with cost of $5 billion in 2012
Nonalcoholic Fatty Liver Disease Predicts MACE in STEMI
Patients with moderate to severe fatty liver disease more likely to have impaired myocardial infusion
Low-Dose Rifaximin Cuts Endotoxin Level in Cirrhosis
Similar reduction in serum endotoxin level for low-dose, high-dose rifaximin
FDA Requires New Warning on Two Hepatitis C Drugs
Cautionary label will be added to Viekira Pak and Technivie, agency says
Stricter Alcohol Policy Tied to Lower Rates of Cirrhosis Mortality
Strongest link between alcohol policies and alcoholic cirrhosis deaths seen in northeastern U.S.
Elevated Liver Enzymes Common in Severe Anorexia Nervosa
Elevated AST, ALT linked to lower BMI, development of hypoglycemia, hypophosphatemia
